Changzhou Kangpu Pharmaceutical Co., Ltd., established on 1979-12-01, Business range includes tablet,hard capsule,oral liquid,cream,API,Narcotic Drugs,Traditional Chinese medicine pretreatment and extraction manufacturing;Self-operated and agent import and export business of various commodities and technologies,Except for the goods and technologies that the state restricts the company to operate or prohibits the import and export of.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) licensed items:Pharmaceutical commissioned production(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Specialty Chemicals Sales(Free of Hazardous Chemicals);New material technology research and development;New material technology promotion service;Research and development of bio-based materials technology;Manufacturing of bio-based materials;Sales of bio-based materials;Biochemical product technology research and development;Medical Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Storage equipment rental service;Non-residential real estate leases(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Changzhou Pharmaceutical Factory (CPF) is a leading pharmaceutical manufacturer of APIs , finished formulations in China. Located in Changzhou, Jiangsu province and has a history of more than half a century. It covers an area of 110,000m2 and employs 900 staffs, including more than 300 technicians with different specialties.

Donggang Hongda Pharmaceutical Co., Ltd., established on 2003-07-28, Business scope includes licensed projects:pharmaceutical production,Hazardous Chemicals Management(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Technology Import and Export,Import and export(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Guangdong Nanguo Pharmaceutical Co., Ltd., established on 1977-06-02, Business scope includes licensed projects:pharmaceutical production;road freight transport(Does not contain dangerous goods).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Import and export;Technology Import and Export.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Zhengzhou Taifeng Pharmaceutical Co., Ltd., established on 1998-06-28, Business scope includes licensed projects:pharmaceutical production;Pharmaceutical commissioned production;Drug import and export;Drug Wholesale;Drug retail;Drug internet information service(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Manufacturing of basic chemical raw materials(Manufacture of licensed chemicals free of hazardous chemicals);Chemical product production(No licensed chemical products);Chemical product sales(No licensed chemical products);Medical Research and Experimental Development;R&D and application of cell technology;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;sales agent;Conference and Exhibition Services(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Tianjin Pharmaceutical Group Xinzheng Co., Ltd. is a pharmaceutical company in China. It offers medicines in forms of water injection, tablets, capsules, granules, ointments, gels, raw materials & oral solution. The company is headquartered in Tianjin, CN.

Kyoto Pharmaceutical Industries Ltd. engages in pharmaceutical products manufacturing. Its products include pharmaceuticals to regulate high-blood pressure, Ischemic heart disease treatment, digitalis formulation, and constipation remedies. The firm also develops and produces laxatives, anti-flatulence and anti-diarrheal medicines, and decongestants and cold medicines. The company was founded on September 5, 1946 and is headquartered in Kyoto, Japan.

Part of Shanghai Pharmaceuticals Holding Co., Ltd., Shanghai Sine Pharmaceutical Co. Ltd. is a Chinese company located in Shanghai. The firm manufactures and distributes pharmaceutical products. It was acquired by Shanghai Pharmaceuticals Holding Co., Ltd. from Shanghai Pharmaceutical (Group) Co., Ltd. on February 03, 2010 for $124.70 million.

Zhengzhou Chenghe Information Technology Co., Ltd., established on 2016-09-21, Business scope includes technical development of computer software;technology development in computer technology,technology transfer,technical consulting,Technical Services.

Qianhui Pharmaceutical (Anhui) Co., Ltd., established on 2006-10-18, Business scope includes pharmaceutical intermediates,API(loxoprofen sodium,Celecoxib,Eperisone Hydrochloride)research and development,production and sales;Self-operation and agency of various commodities and technology import and export business(Except for commodities and technologies that are restricted by the state to be operated by enterprises or prohibited from import and export).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Zhengzhou Zhangmeng Network Technology Co., Ltd., established on 2015-05-18, Business scope includes general items:Toy,Animation and entertainment goods sales;Other cultural and art brokerage agents;Digital culture creative software development;literary creation;software development;graphic design;Digital Content Production Services(Does not include publishing);Film and television art props setting service(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Jiangsu Baozhong Baoda Pharmaceutical Co., Ltd., established on 2006-02-16, The scope of business includes mefentrazone,Sulfentrazone(Sophohydrazone),Clomazone(Clomazone),Fenbendazole(Benthimazole),Oxfendazole,Flubendazole,Carbohydrazone,Sofenamide,Benzene sulfur condensate,Fluorobenzene Condensate,by-product:Production and mixing of waste nitrification mixed acid(dilution)40%Acetaldehyde,Sell ​​self-produced products;Cimetidine,Dextromethorphan Hydrobromide,Clophenedol,Lithium hydroxide monohydrate,Apixaban,Linagliptin,Promethazine Hydrochloride,trimethylolpropane(2-Methyl-1-Aziridine propionate)and by-products:lithium hydroxide solution,calcium carbonate,hydrochloric acid,dilute sulfuric acid,sodium sulfate decahydrate,Production and sales of potassium chloride;Development of famotidine,Production and sales.(Items subject to approval by law,Business activities can only be carried out with the approval of relevant departments)

Shanghai Xinyi Bailuda Pharmaceutical Co., Ltd., established on 1997-07-25, Business scope includes pharmaceutical preparations,API,Manage the export business of the company's self-produced products and technologies;Raw and auxiliary materials required for the production of the enterprise,Instrumentation,Equipment,Import business of spare parts and technology(The state restricts the operation of the company and the state prohibits the import and export of goods except);operating incoming material processing and"Three to one make up"business,Operation of pharmaceutical research and development technical services,consultation service,Exhibition business service,Operating the machinery and equipment leasing business of the enterprise. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Zhengzhou Renhong Pharmaceutical Technology Co., Ltd., established on 2015-11-20, The scope of business includes the development of medical technology,technology transfer;Sales of medical equipment,technical consulting,Technical Services;Technology development of computer hardware and software,technology transfer,technical consulting,Technical Services;Computer Data Processing Services;Computer System Integration Services.

Tonghua Wantong Pharmaceutical Co. Ltd. (doing business as Wantong Pharmacy) is a Chinese private company that manufactures traditional medicine.

Shanghai Modern Pharmaceutical Preparation Engineering Research Center Co., Ltd., established on 1996-06-10, Business scope includes general items:Chinese and Western medicine preparations,Health care pharmaceutical preparations,Technology development on the application technology of pharmaceutical excipients,technical consulting,Technical Services,technology transfer;Design of preparation equipment,analyze;Pharmaceutical Raw Materials,Research on Testing Technology of Packaging Materials;Sales of preparation equipment;Own house rental.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license) licensed items:Inspection and testing service.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Baxter International Inc. develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The company operates through three segments: BioScience, Medication Delivery, and Renal. - The BioScience segment manufactures recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha 1-antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; products for regenerative medicine, such as biosurgery products and technologies used in adult stem-cell therapies; and vaccines. - The Medication Delivery segment manufactures intravenous solutions and administration sets; premixed drugs and drug-reconstitution systems; pre-filled vials and syringes for injectable drugs, intravenous nutrition products; infusion pumps; and inhalation anesthetics. This segment also offers products and services related to pharmacy compounding, drug formulation, and packaging technologies. - The Renal segment provides products to treat end-stage renal disease and irreversible kidney failure. This segment also offers solutions and other products for peritoneal dialysis, a home-based therapy and product for hemodialysis, which is conducted in a hospital or clinic. Baxter International Inc. has collaborations with HHD LLC, DEKA Products Limited Partnership, and DEKA Research and Development Corp. for the development of a home hemodialysis machine. It markets its products to hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors offices, clinical and medical research laboratories, and patients at home under physician supervision. The company was founded in 1931 and is headquartered in Deerfield, Illinois.

Yabao Pharmaceutical Group Co., Ltd. engages in the development, production, and sale of pharmaceutical products. It focuses on medicine and health business. The company's products include Chinese and western medicine preparations, raw materials, and pharmaceutical packaging materials, mainly for the elderly chronic drug and women and children medication; cardiovascular and cerebrovascular drugs, and health products. It also involves in the cultivation of Chinese herbal medicines. Yabao Pharmaceutical Group was founded on January 26, 1999 and is headquartered in Beijing. China.

Wuhan Weilide Biopharmaceutical Co., Ltd., established on 2012-12-24, The scope of business includes research and development of biomedical products and related technical services.(In the scope of the above, the state-owned special regulations need to be examined and approved. The project can only be operated after approval or with a valid license.)

Shenyang Oasis Pharmaceutical Co., Ltd., established on 2001-09-17, Business range includes tablet,hard capsule,Granules,mixture,syrup,emulsion,gel(Including external use),soft capsule,API production;crop planting,Sales(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)